Surgery Partners, Inc.
Surgery Partners, Inc. (SGRY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
sgry · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Surgery Partners, Inc. (SGRY) measures how much investors pay for each dollar of the company's trailing earnings. SGRY's current PE ratio of N/A is calculated by dividing its stock price of $13.79 by its TTM earnings per share of -$0.59.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2012 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 3 fiscal years · Front-end computedMinQ1 · 25%477.5x
MedianQ3 · 75%517.1x
Max
At N/A, SGRY's current P/E is lower than in 0% of its annual fiscal year readings over the past 3 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Surgery Partners, Inc.You SGRY | $1.8B | N/A | — | -$0.59 |
 Ardent Health Partners, LLC ARDT | $1.2B | 9.15x | — | $0.96 |
 Alphatec Holdings, Inc. ATEC | $1.2B | N/A | — | -$0.96 |
 Brookdale Senior Living Inc. BKD | $2.8B | N/A | — | -$1.12 |
 Cidara Therapeutics, Inc. CDTX | $5.6B | N/A | — | -$26.75 |
 Heartflow, Inc. Common Stock HTFL | $2.5B | N/A | — | -$0.32 |
 IDEAYA Biosciences, Inc. IDYA | $2.7B | N/A | — | -$1.28 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.61 | — | |
2024-12-31 FY2024 | — | $-1.33 | — | |
2023-12-31 FY2023 | — | $-0.09 | — | |
2022-12-31 FY2022 | — | $-0.59 | — | |
2021-12-31 FY2021 | — | $-0.98 | — | |
2020-12-31 FY2020 | — | $-2.38 | — | |
2019-12-31 FY2019 | — | $-1.55 | — | |
2018-12-31 FY2018 | — | $-4.28 | — | |
2017-12-31 FY2017 | — | $-1.09 | — | |
2016-12-31 FY2016 | 80.51x | $0.20 | -84.4% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Surgery Partners, Inc. (SGRY) measures how much investors pay for each dollar of the company's trailing earnings. SGRY's current PE ratio of N/A is calculated by dividing its stock price of $13.79 by its TTM earnings per share of -$0.59.
Frequently asked questions
SGRY pe ratio · 6 questionsSGRY's current PE ratio is N/A as of 2026-06-08, based on a stock price of $13.79 and TTM EPS of -$0.59. Data sourced from Financial Modeling Prep via SGRY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Surgery Partners, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08